MBXBF (Microbix Biosystems) Retained Earnings: $-27.87 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MBXBF Microbix Biosystems Inc MBXBF
53 GF Score
Price $0.21
GF Value $0.17
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Microbix Biosystems Retained Earnings?

Microbix Biosystems MBXBF -1.12% 53 Retained Earnings is $-27.87 Mil as of Mar. 2026. GuruFocus rates MBXBF with a GF Score™ of 53/100 and a GF Value™ of $0.17 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Microbix Biosystems's retained earnings for the quarter that ended in Mar. 2026 was $-27.87 Mil.

Microbix Biosystems's quarterly retained earnings declined from Sep. 2025 ($-25.76 Mil) to Dec. 2025 ($-26.68 Mil) and declined from Dec. 2025 ($-26.68 Mil) to Mar. 2026 ($-27.87 Mil).

Microbix Biosystems's annual retained earnings increased from Sep. 2023 ($-27.28 Mil) to Sep. 2024 ($-24.65 Mil) but then declined from Sep. 2024 ($-24.65 Mil) to Sep. 2025 ($-25.76 Mil).


Microbix Biosystems  (OTCPK:MBXBF) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Microbix Biosystems Retained Earnings Historical Data

* Premium members only.

The historical data trend for Microbix Biosystems's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbix Biosystems Retained Earnings Chart

Microbix Biosystems Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only -30.51 -27.64 -27.28 -24.65 -25.76

Microbix Biosystems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.65 -24.99 -25.76 -26.68 -27.87
MBXBF
53GF Score
Microbix Biosystems Inc MBXBF
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Microbix Biosystems Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $-27.87 Mil mean?
Microbix Biosystems (MBXBF) has a Retained Earnings of $-27.87 Mil as of Mar. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Microbix Biosystems and its competitors.
Is Microbix Biosystems' Retained Earnings too high?
Microbix Biosystems' current Retained Earnings is $-27.87 Mil. Overall, Microbix Biosystems has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Microbix Biosystems' Retained Earnings compare to VRTX and REGN?
Microbix Biosystems' Retained Earnings of $-27.87 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Biotechnology company?
A good Retained Earnings depends on the Biotechnology industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Microbix Biosystems and its competitors. Microbix Biosystems's current Retained Earnings is $-27.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbix Biosystems stock overvalued right now?
Based on GuruFocus' analysis, Microbix Biosystems (MBXBF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.17, compared to a current price of $0.21 — trading 25.1% above its estimated fair value. The current Retained Earnings is $-27.87 Mil. Microbix Biosystems' overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Microbix Biosystems (MBXBF), the current Retained Earnings is $-27.87 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Microbix Biosystems (MBXBF) Overvalued in 2026?

Based on GuruFocus' analysis, Microbix Biosystems stock appears to be overvalued. The current stock price of $0.21 is trading 25.1% above its estimated GF Value™ of $0.17. GuruFocus considers Microbix Biosystems to be Modestly Overvalued.

Key valuation signals for MBXBF:

  • Retained Earnings: $-27.87 Mil
  • GF Value™: $0.17 vs. price of $0.21 (25.1% above fair value)
  • GF Score™: 53/100 with 8 warning signs

No single metric tells the full story. See the MBXBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Microbix Biosystems Business Description

Other Exchanges MBX:Canada
Address 265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows, and viral transport medium to enable collection of patient test samples; and the development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.
53GF Score

Get the complete analysis for MBXBF

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.21
Price
$0.17
GF Value